Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2019 - 2022)
Rigel Pharmaceuticals (RIGL) posted quarterly Other Working Capital Changes of -$145000.0 for Q1 2026, down 114.01% year-over-year from $1.0 million in Q1 2025, and down 2.84% quarter-over-quarter from -$141000.0 in Q4 2025.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2019 - 2022) Analysis & Trends
Rigel Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$145000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 114.01% year-over-year to -$145000.0; the TTM figure through Mar 2026 stood at -$456000.0 (down 189.24% YoY), while the FY2025 annual figure was $724000.0, up 204.62% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$145000.0, down from -$141000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $13.2 million in Q1 2025, with the low at -$6.6 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $1.4 million (2024), against an average of $1.0 million.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes plunged 447.13% in 2023, then surged 716.07% in 2025.
- Rigel Pharmaceuticals' Other Working Capital Changes stood at -$174000.0 in 2022, then advanced by 6.9% to -$162000.0 in 2023, then declined by 11.73% to -$181000.0 in 2024, then rose by 22.1% to -$141000.0 in 2025, then retreated by 2.84% to -$145000.0 in 2026.
- Business Quant data shows RIGL's Other Working Capital Changes at -$145000.0 in Q1 2026, -$141000.0 in Q4 2025, and -$81000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 901.09 Mn | 805.76 Mn | 70.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -174,000.00 |
| Sep 30, 2022 | -174,000.00 |
| Jun 30, 2022 | -554,000.00 |
| Jun 30, 2022 | -554,000.00 |
| Mar 31, 2022 | -499,000.00 |
| Mar 31, 2022 | -499,000.00 |
| Dec 31, 2021 | -561,000.00 |
| Dec 31, 2021 | -561,000.00 |
| Sep 30, 2021 | -2.66 Mn |
| Sep 30, 2021 | -2.66 Mn |
| Jun 30, 2021 | -3.69 Mn |
| Jun 30, 2021 | -3.69 Mn |
| Mar 31, 2021 | 6.48 Mn |
| Mar 31, 2021 | 6.48 Mn |
| Dec 31, 2020 | -152,000.00 |
| Dec 31, 2020 | -152,000.00 |
| Jun 30, 2020 | -396,000.00 |
| Jun 30, 2020 | -396,000.00 |
| Mar 31, 2020 | -23.08 Mn |
| Mar 31, 2020 | -23.08 Mn |